E. Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation, Novosibirsk, Russian Federation.
Federal Center of Cardiovascular Surgery, Khabarovsk, Russian Federation.
Heart Vessels. 2023 Jul;38(7):881-888. doi: 10.1007/s00380-023-02236-x. Epub 2023 Jan 25.
The optimal approach for prevention of cardiovascular events and reduction of bleeding in patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) is still controversial. The aim of our study is to asses our single-center experience with concomitant left atrial appendage occlusion (LAAO) and percutaneous coronary intervention (PCI). 50 patients with ACS without ST elevation and history of AF were randomized after successful PCI to LAAO or conventional medical therapy. The primary endpoints were safety and length of hospitalization. The follow-up period was 30 days. The mean procedural times were 113 ± 23 min PCI + LAAO implantation and 39 ± 19 min of PCI only (p < 0.001), while mean fluoroscopy times were 18 ± 8 min and 12 ± 8 min (p < 0.001), respectively. No procedure-related complications were observed. There was no difference observed for length of hospitalization between two groups. LAAO in patients with ACS and AF undergoing PCI appears safe.
在急性冠状动脉综合征(ACS)和心房颤动(AF)患者中预防心血管事件和减少出血的最佳方法仍存在争议。我们的研究旨在评估我们单中心在左心耳封堵(LAAO)和经皮冠状动脉介入治疗(PCI)同时进行方面的经验。50 例无 ST 段抬高且有 AF 病史的 ACS 患者在成功 PCI 后随机分为 LAAO 或常规药物治疗。主要终点是安全性和住院时间。随访时间为 30 天。平均手术时间为 PCI+LAAO 植入术 113±23 分钟,仅 PCI 为 39±19 分钟(p<0.001),而平均透视时间分别为 18±8 分钟和 12±8 分钟(p<0.001)。未观察到与手术相关的并发症。两组患者的住院时间无差异。在接受 PCI 的 ACS 和 AF 患者中进行 LAAO 似乎是安全的。